🇵🇱 Poland · EU Public Tender
Koncentrat rekombinowanego czynnika krzepnięcia VIII minimum II generacji, części: 1÷2
🏛️ Krajowa Izba Odwoławcza · 📍 Warszawa
3.3M €
Estimated value
09 August 2024
Deadline
| Contract type | Supplies |
| CPV | 33621000 |
| Deadline | 09 August 2024 |
| Awarded to | Takeda Pharma Sp. z o. o. |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.